Sort   by:  
 Page size 
UnknownFavourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3-5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
Not available
S-EPMC7487775 | biostudies-literature
UnknownFavourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trial.
Not available
S-EPMC9176097 | biostudies-literature
UnknownRegional disparities and seasonal differences in climate risk to rice labour.
Not available
S-EPMC8592055 | biostudies-literature
UnknownDurable Responses and Low Toxicity After Fast Off-Rate CD19 Chimeric Antigen Receptor-T Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia.
Not available
S-EPMC8791810 | biostudies-literature
UnknownDiagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia.
Not available
S-EPMC10405200 | biostudies-literature
UnknownHerd-level risk factors associated with tuberculosis breakdowns among cattle herds in England before the 2001 foot-and-mouth disease epidemic.
Not available
S-EPMC1629052 | biostudies-literature
UnknownLong-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrom macroglobulinaemia.
Not available
S-EPMC7617639 | biostudies-literature
UnknownMaximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma.
Not available
S-EPMC6960465 | biostudies-literature
UnknownCulling and cattle controls influence tuberculosis risk for badgers.
Not available
S-EPMC1586183 | biostudies-literature
UnknownDeterminants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
Not available
S-EPMC6167406 | biostudies-literature
Sort   by:  
 Page size